Pouring oil into the fire? on the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease

Psychopharmacology

Volumn 179, Issue 1, 2005, Pages 151-153

  Schmitt, H Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PYRUVATE DEHYDROGENASE;

ALZHEIMER DISEASE; AROUSAL; ATTENTION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DENTATE NUCLEUS; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; DRUG EFFICACY; EMOTIONAL STABILITY; EVIDENCE BASED MEDICINE; FOREBRAIN; GABAERGIC SYSTEM; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROMODULATION; NOTE; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SIGNAL NOISE RATIO;

ALZHEIMER DISEASE; CALCIUM; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 17744365166     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2110-5     Document Type: Note

References (21)

1. 7 nicotinic than NMDA receptors: implications for treatment of Alzheimer's disease. Neurobiol Aging 25(S2): S217, No. 416
2. Beal MF (2000) Oxidative metabolism. Ann NY Acad Sci 924:164-169
3. Burghaus L, Schütz U, Krempel U, de Vos RA, Jansen-Stair E.N, Wevers A, Lindström J, Schröder H (2000) Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res 76:385-388
4. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464
5. Farber NB, Newcomer JW, Olney JW (1998) The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res 116:421-437
6. Graf RA, Kater SB (1998) Inhibitory neuronal activity can compensate for adverse effects of β-amyloid in hippocampal neurons. Brain Res 786:115-121
7. 3H]glutamate binding. J Neurochem 83:543-551
8. Guan ZZ, Zhang X, Ravid R, Nordberg A (2000) Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243
9. Hirano T, Watanabe D, Kawaguchi S-Y, Pastan I, Nakanishi S (2002) Roles of inhibitory interneurons in the cerebellar cortex. Ann NY Acad Sci 978:405-512
10. Kandel ER (2001) The molecular biology of memory storage: a dialog between genes and synapses. Biosci Rep 21:565-611
11. Lee H, Ogawa O, Zhu X, O'Neill MJ, Petersen RB, Castellani RJ, Ghanbari H, Perry G, Smith MA (2004) Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease. Acta Neuropathol 107:365-371
12. Mattson MP, Furukawa K (2003) Dysregulation of calcium signaling in Alzheimer's pathogenesis: impact on neuronal synaptic plasticity and cell death, neurogenesis, and glial functions. In: Iqbal K, Winblad B (eds) Alzheimer's disease and related disorders: research advances. "Ana Asian" Internat Acad Aging, Bucharest, Romania, pp 433-443
13. Meier-Ruge W, Bertoni-Feddari C (1996) The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev Neurosci 7:1-19
14. Palmer AM (1996) Neurochemical studies of Alzheimer's disease. Neurodegeneration 5:381-391
15. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333-1341
16. Ribary U, Ioannides AA, Singh KD, Hasson R, Bolton JP, Lado F, Mogilner A, Llinás R (1991) Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. Proc Natl Acad Sci U S A 88:11037-11041
17. Rowan MJ, Klyubin I, Cullen WK, Anwyl R (2004) Synaptic plasticity in animal models of early Alzheimer's disease. In: Bliss T, Collingridge G, Morris R (eds) LTP. Long-term potentiation enhancing neuroscience for 30 years. Oxford University Press, Oxford, NY, pp 357-370
18. Schneider LS (2004) AD2000: donepezil in Alzheimer's disease. Lancet 363:2100-2101
19. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil. JAMA 291:317-324
20. Traub R, Bibbig A, LeBeau FEN, Buhl EH, Whittington JGR (2004) Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro. Annu Rev Neurosci 27:247-278
21. Yang Y, Beyreuther K, Schmitt HP (1999) Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary degenerative and vascular dementia: a comparative immunocytochemical and quantitative study using a graph method. Anal Cell Pathol 19:125-138